第66届美国血液学年会(American Society of Hematology Annual Meeting,ASH)于2024年12月7～10日在美国圣迭戈召开。ASH是全球最大、最具影响力的血液学领域学术会议之一,每年吸引来自世界各地的血液学专家交流最新的研究成果、临床实践和治疗进展...
2024 ASH摘要新鲜出炉 2024年12月7日至10日,第66届美国血液学会(ASH)年会将以线上结合线下的形式在美国圣地亚哥(San Diego)盛大召开。届时,来自全球近100个国家和地区的数万名血液病专家、学者及行业相关人士莅临参会,分享和探讨全球最...
2024 ASH Annual MeetingDaniela MarínLan-Lan SmithThe Lancet Haematology
The ASH Annual Meeting virtual platform opens on Wednesday, December 4, 2024, to all attendees. Most sessions offered in San Diego will be broadcast simultaneously on the virtual platform. Once a session takes place, the platform will include an on-demand recording of the session. There are th...
[1]. https://www.hematology.org/Meetings/Annual-Meeting [2]. https://ash.confex.com/ash/2024/webprogram/start.html [3]. 王天怡,等. 国际输血及血液学杂志. 2017;40(1):56-61. [4]. 国家卫生健康委员会弥漫性大B 细胞淋巴瘤诊疗指南(2022年版) ...
Attendees will have the opportunity to register for the in-person meeting in San Diego or via one of the virtual registration options.If you choose to participate in person, you will also receive complimentary access to the annual meeting virtual platform through January 1, 2024 (with the opport...
America to Present New Investigational Data at the 2024 American Society of Hematology Annual Meeting. Retrieved Nov 6, 2024, from https://news.us.sumitomo-pharma.com/2024-11-06-Sumitomo-Pharma-America-to-Present-New-Investigational-Data-at-the-2024-American-Society-of-Hematology-Annual-Meeting ...
Dr Nadia Ali shares insights from the 2024 ASH annual meeting that have informed her clinical practice, particularly in managing pregnant patients withanemiaand those with hemoglobinopathies likesickle cell disease. On the basis of data comparing high-dose and low-dose intravenous (IV) iron, Dr ...
Recapping ASH, Hematology Updates from 2024 : Episode 1 News Video December 17, 2024 Recapping ASH 2024 Highlights, with Steven Fein, MD Author(s): Steven Fein, MDIn this video, Steven Fein, MD, discusses updates and topics of note from the American Society of Hematology annual meeting....
Merck, known as MSD outside of the United States and Canada, today announced that new data for approved and investigational medicines across multiple hematologic malignancies will be presented at the American Society of Hematology Annual Meeting and Expo